Question 1

Does Morgan Stanley own MYGN stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Morgan Stanley holds 2,481,104 shares of MYGN (Myriad Genetics), worth $14.2M.

Question 2

How many shares of MYGN does Morgan Stanley own?

Accepted Answer

As of its Q2 2026 13F, Morgan Stanley holds 2,481,104 shares of MYGN (Myriad Genetics).

Question 3

What is Morgan Stanley's MYGN position worth?

Accepted Answer

As of its Q2 2026 13F, Morgan Stanley's MYGN position is worth $14.2M.

Question 4

Is Morgan Stanley buying or selling MYGN?

Accepted Answer

In Q2 2026, Morgan Stanley reduced its MYGN position by 687,638 shares (-21.7%).

Question 5

When did Morgan Stanley first buy MYGN?

Accepted Answer

Morgan Stanley already held MYGN in its Q2 2024 13F, the earliest on record, and has listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	2.5M	-21.7%	$14.2M	0.0%	$5.71	0
2026-Q1	Decreased	3.2M	-12.2%	$14.3M	0.0%	$4.50	0
2025-Q4	Decreased	3.6M	-0.3%	$22.2M	0.0%	$6.15	0
2025-Q3	Decreased	3.6M	-20.6%	$26.2M	0.0%	$7.23	0
2025-Q2	Increased	4.6M	+182.1%	$24.2M	0.0%	$5.31	46
2025-Q1	Increased	1.6M	+25.6%	$14.3M	0.0%	$8.87	35
2024-Q4	Increased	1.3M	+45.9%	$17.6M	0.0%	$13.71	38
2024-Q3	Decreased	880,987	-35.8%	$24.1M	0.0%	$27.39	0

MYGNShowing 8 of 9 quarters

MYGN
Showing 8 of 9 quarters